CCI approves HDFC Life’s 100 per cent acquisition of Exide Life Insurance

[ad_1]

Read More/Less


The Competition Commission of India (CCI) has approved HDFC Life Insurance’s acquisition of 100 per cent shareholding in Exide Life Insurance, a unit of battery manufacturer Exide Industries.

It may be recalled that HDFC Life had in early September announced that it would acquire the entire share capital of Exide Life Insurance for a total consideration of ₹6,687 crore. This deal is expected to help HDFC Life strengthen its presence in South India, a region where Exide Life has a strong foothold.

“Commission approves acquisition of 100 per cent equity share capital of Exide Life Insurance Company Limited by HDFC Life Insurance Company Limited and the subsequent merger of Exide Life with HDFC Life,” CCI tweeted on Tuesday evening.

The proposed combination involves acquisition of fully paid-up equity shares, representing 100 per cent of target by the Acquirer from Exide Industries Limited.

After completion of the share acquisition, Exide Life (which will be a wholly owned subsidiary of HDFC Life) is proposed to be merged with HDFC Life.

HDFC Life is India’s most valuable private life insurer. It offers a range of individual and group life insurance solutions including participating, non-participating and unit linked insurance products.

[ad_2]

CLICK HERE TO APPLY

Rupee strengthens vs dollar on IPO flows; gains capped before US FOMC statement, BFSI News, ET BFSI

[ad_1]

Read More/Less


NEW DELHI: The rupee strengthened marginally versus the US dollar on Wednesday because of a drop in global crude oil prices and on the back of dollar sales by foreign banks for overseas investments in initial public offerings of Indian companies, dealers said.

The domestic currency on Wednesday opened at 74.60 against the US dollar as against 74.6775 at the previous close. The local unit, which was last at 74.5550 versus the greenback, moved in the range of 74.5375-74.6425 so far in the day.

Crude oil prices declined, providing some relief for traders on the twin fronts of inflation and the trade deficit. India is the world’s third-largest importer and consumer of crude oil.

Oil futures for December delivery on the New York Mercantile Exchange declined 0.2 per cent to close at $83.91 per barrel on Tuesday.

The rupee had also gained sharply on Tuesday on account of flows for overseas investment into local companies, with the domestic currency adding 0.3 per cent versus the greenback.

“There were flows for Policybazaar IPO etc. And now we have Paytm IPO lined up as well next week,” a dealer with a private bank said on condition of anonymity.

“Oil seems to have stabilised a bit after the surge of this month. But having said that, we don’t expect a major degree of appreciation before the Fed’s statement. Whatever they say on tapering is going to set the tone for markets,” he said.

The US Federal Open Market Committee is scheduled to release its monetary policy statement late Wednesday.

Details of a potential rollback in quantitative easing in the world’s largest economy may play a major role in overseas investors’ appetite for emerging market currencies such as the rupee.

Government bonds were steady, with the yield on the 10-year benchmark 6.10 per cent 2031 paper unchanged at 6.36 per cent. Bond prices and yields move inversely.

Bond traders kept to the sidelines in a heavily truncated week. The market will be shut on Thursday and Friday on account of Diwali and Diwali Balipratipada.



[ad_2]

CLICK HERE TO APPLY

Goldman Sachs promotes 30 executives as MDs in India, the largest ever in the country, BFSI News, ET BFSI

[ad_1]

Read More/Less


Leading global investment bank Goldman Sachs has promoted 30 executives in its India offices to the managing director (MD) position, the largest ever group of new MDs the company has promoted in the country.

The highest ever number of new MD promotions in India is a reflection of the company’s investment in the country, a key footprint and a deep fintech hub globally. In the 2019 MD promotion cycle, the company had 18 managing director promotions in India, which represents the second largest presence of the firm outside of New York.

Globally, the company promoted 643 employees as MDs this year, which includes 71 Indians, making it the largest MD class to date globally, the company said in a note. The new MDS will take charge on January 1.

In India, there was one managing director promotion in the Mumbai office and 29 promotions in the company’s Bengaluru office. The firm opened a new Hyderabad office in July this year.

Goldman Sachs has more than 8,000 employees in India and employs more than 43,000 professionals globally.

The Bengaluru and Hyderabad offices represent a ‘deep fintech hub’ of the firm and a key enabler of its existing and new businesses.

Over 25% of the promotions are women and more than 50% are from engineering functions.

Globally, the promotions this year are reflective of the firm’s strategic priorities, including investments in core businesses (investment banking division and global markets); growth strategies (asset management, consumer and engineering); and strategic locations (particularly Bengaluru, Salt Lake City and Dallas), the company said.

In the entire cohort of MDs promoted globally this year, overall 20% of the promotions are from engineering functions, while 72 from strategic locations represents 11% of the overall class and is two times the total number promoted in 2019.

This is also the most diverse group with 30% women, 28% Asian and 3% LGBTQ, according to the company.



[ad_2]

CLICK HERE TO APPLY

Government’s Kisan Vikas Patra (KVP) Scheme To Double Your One-time Investment

[ad_1]

Read More/Less


Interest rate and deposits

The government’s Kisan Vikas Patra (KVP) scheme is currently attracting an interest rate of 6.9%, which is compounded annually, as per recent rule. The minimum amount to open a Kisan Vikas Patra (KVP) account is Rs. 1000 and in multiples of Rs. 100. There is no bar on the maximum amount. It is a safe investment tool, with the security of the union government.

Benefits of the Kisan Vikas Patra (KVP) scheme

Benefits of the Kisan Vikas Patra (KVP) scheme

The invested amount, whatever is, will double in 10 years and 4 months (124 months), according to the rule. You can open any number of accounts under this scheme. So, using the KVP calculator, if you are investing a lump sum of Rs. 1,00,000, at once, your total return will be Rs. 2,00,000 after 10 years and 4 months. According to Post Office, “The deposit shall mature on the maturity period prescribed by the Ministry of Finance from time to time as applicable on the date of deposit.”

Eligibility

Eligibility

Any single adult can open the Kisan Vikas Patra (KVP) account under a Post Office. In the case of a Joint Account, up to 3 adults will be allowed. However, if you are a guardian, you can open the account on behalf of your children. Along with that, on behalf of a minor or on behalf of a person of unsound mind, you can open the account. On the other hand, a minor above 10 years can open an account in his name.

Premature closure

Premature closure

In case of premature closure, the Post Office has certain rules that follow:

(i) On the death of a single account, or any or all the account holders in a joint account.

(ii) On forfeiture by a pledgee being a Gazette officer.

(iii) When order by court.

(iv) After 2 years and 6 months from the date of deposit.

(f) Transfer of account from one person to another person.

One can also check Public Provident Fund (PPF) Scheme to get assured return after a certain period for better interest rate, guaranteed by the union government.



[ad_2]

CLICK HERE TO APPLY

Profit may double, NIM likely in 3-3.1% range, BFSI News, ET BFSI

[ad_1]

Read More/Less


NEW DELHI: State Bank of India (SBI) may report up to 100 per cent surge in net profit for September quarter on a marginal rise in net interest income (NII). Net interest margin (NIM) is seen healthy at 3-3.1 per cent. Analysts said healthy NIM, recovery from DHFL and lower loan loss provision should lead to strong profitability, which may partly be offset by the hit on NPS/pension for retired personnel.

Slippages should remain moderate, with limited NPAs in retail, said Emkay Global, which said the stress in SME could be taken out via restructuring.

This brokerage is expecting the bank to report 58.5 per cent YoY rise in net profit at Rs 7,249.80 crore compared with Rs 4,574.20 crore in the same quarter last year. It sees NII rising 2.4 per cent to Rs 28,856.30 crore from Rs 28,181.50 crore YoY. NIM is seen at 3 per cent compared with 2.9 per cent in June quarter and 3.1 per cent in the year-ago quarter.

Nirmal Bang Institutional Equities is pegging profit at Rs 7,646.60 crore, up 67.2 per cent YoY. NII is seen growing 3.8 per cent YoY to Rs 29,263.30 crore. Pre-provision profit is seen at Rs 18,792.30 crore, up 14.2 per cent.

The bank is seen reporting a loan growth of 8.1 per cent YoY to Rs 24,80,546.20 crore and deposit growth of 8.6 per cent at Rs 37,69,359.80 crore. Credit cost is seen at 1.4 per cent.

“SBI should continue to report better NII growth of 3.5 per cent YoY, loan growth of 8 per cent on lower interest reversals. We build higher slippages from Agri and SME segments, while we build in recovery from DHFL,” Prabhudas Lilladher said.

This brokerage is expecting a 102 per cent surge in profit at Rs 9,263 crore. It sees NIM at 3.05 per cent while gross NPA is seen at 5.83 per cent.



[ad_2]

CLICK HERE TO APPLY

Reserve Bank of India – Press Releases

[ad_1]

Read More/Less



(Amount in ₹ crore, Rate in Per cent)

  Volume
(One Leg)
Weighted
Average Rate
Range
A. Overnight Segment (I+II+III+IV) 4,55,086.48 3.35 1.00-5.25
     I. Call Money 12,826.21 3.34 2.00-3.50
     II. Triparty Repo 3,29,183.25 3.36 3.15-3.68
     III. Market Repo 1,13,047.02 3.34 1.00-3.55
     IV. Repo in Corporate Bond 30.00 5.25 5.25-5.25
B. Term Segment      
     I. Notice Money** 996.82 3.26 2.50-3.50
     II. Term Money@@ 234.00 3.35-3.99
     III. Triparty Repo 3,555.40 3.35 3.35-3.38
     IV. Market Repo 0.00
     V. Repo in Corporate Bond 0.00
  Auction Date Tenor (Days) Maturity Date Amount Current Rate /
Cut off Rate
C. Liquidity Adjustment Facility (LAF) & Marginal Standing Facility (MSF)
I. Today’s Operations
1. Fixed Rate          
     (i) Repo          
    (ii) Reverse Repo Tue, 02/11/2021 1 Wed, 03/11/2021 2,50,222.00 3.35
    (iii) Special Reverse Repo~          
    (iv) Special Reverse Repoψ          
2. Variable Rate&          
  (I) Main Operation          
     (a) Reverse Repo          
  (II) Fine Tuning Operations          
     (a) Repo          
     (b) Reverse Repo Tue, 02/11/2021 7 Tue, 09/11/2021 1,50,015.00 3.95
  Tue, 02/11/2021 28 Tue, 30/11/2021 50,007.00 3.97
3. MSF Tue, 02/11/2021 1 Wed, 03/11/2021 264.00 4.25
4. Special Long-Term Repo Operations (SLTRO) for Small Finance Banks (SFBs)£          
5. Net liquidity injected from today’s operations
[injection (+)/absorption (-)]*
      -4,49,980.00  
II. Outstanding Operations
1. Fixed Rate          
    (i) Repo          
    (ii) Reverse Repo          
    (iii) Special Reverse Repo~ Fri, 22/10/2021 12 Wed, 03/11/2021 5,465.00 3.75
    (iv) Special Reverse Repoψ Fri, 22/10/2021 12 Wed, 03/11/2021 2,900.00 3.75
2. Variable Rate&          
  (I) Main Operation          
     (a) Reverse Repo Fri, 22/10/2021 12 Wed, 03/11/2021 4,18,395.00 3.99
  (II) Fine Tuning Operations          
     (a) Repo          
     (b) Reverse Repo          
3. MSF          
4. Long-Term Repo Operations# Mon, 17/02/2020 1095 Thu, 16/02/2023 499.00 5.15
  Mon, 02/03/2020 1094 Wed, 01/03/2023 253.00 5.15
  Mon, 09/03/2020 1093 Tue, 07/03/2023 484.00 5.15
  Wed, 18/03/2020 1094 Fri, 17/03/2023 294.00 5.15
5. Targeted Long Term Repo Operations^ Fri, 27/03/2020 1092 Fri, 24/03/2023 12,236.00 4.40
  Fri, 03/04/2020 1095 Mon, 03/04/2023 16,925.00 4.40
  Thu, 09/04/2020 1093 Fri, 07/04/2023 18,042.00 4.40
  Fri, 17/04/2020 1091 Thu, 13/04/2023 20,399.00 4.40
6. Targeted Long Term Repo Operations 2.0^ Thu, 23/04/2020 1093 Fri, 21/04/2023 7,950.00 4.40
7. On Tap Targeted Long Term Repo Operations Mon, 22/03/2021 1095 Thu, 21/03/2024 5,000.00 4.00
  Mon, 14/06/2021 1096 Fri, 14/06/2024 320.00 4.00
  Mon, 30/08/2021 1095 Thu, 29/08/2024 50.00 4.00
  Mon, 13/09/2021 1095 Thu, 12/09/2024 200.00 4.00
  Mon, 27/09/2021 1095 Thu, 26/09/2024 600.00 4.00
  Mon, 04/10/2021 1095 Thu, 03/10/2024 350.00 4.00
8. Special Long-Term Repo Operations (SLTRO) for Small Finance Banks (SFBs)£ Mon, 17/05/2021 1095 Thu, 16/05/2024 400.00 4.00
Tue, 15/06/2021 1095 Fri, 14/06/2024 490.00 4.00
Thu, 15/07/2021 1093 Fri, 12/07/2024 750.00 4.00
Tue, 17/08/2021 1095 Fri, 16/08/2024 250.00 4.00
Wed, 15/09/2021 1094 Fri, 13/09/2024 150.00 4.00
D. Standing Liquidity Facility (SLF) Availed from RBI$       21,695.80  
E. Net liquidity injected from outstanding operations [injection (+)/absorption (-)]*     -3,19,422.2  
F. Net liquidity injected (outstanding including today’s operations) [injection (+)/absorption (-)]*     -7,69,402.2  
G. Cash Reserves Position of Scheduled Commercial Banks
     (i) Cash balances with RBI as on 02/11/2021 6,24,802.60  
     (ii) Average daily cash reserve requirement for the fortnight ending 05/11/2021 6,36,507.00  
H. Government of India Surplus Cash Balance Reckoned for Auction as on¥ 02/11/2021 0.00  
I. Net durable liquidity [surplus (+)/deficit (-)] as on 08/10/2021 11,92,495.00  
@ Based on Reserve Bank of India (RBI) / Clearing Corporation of India Limited (CCIL).
– Not Applicable / No Transaction.
** Relates to uncollateralized transactions of 2 to 14 days tenor.
@@ Relates to uncollateralized transactions of 15 days to one year tenor.
$ Includes refinance facilities extended by RBI.
& As per the Press Release No. 2019-2020/1900 dated February 06, 2020.
* Net liquidity is calculated as Repo+MSF+SLF-Reverse Repo.
# As per the Press Release No. 2020-2021/287 dated September 04, 2020.
^ As per the Press Release No. 2020-2021/605 dated November 06, 2020.
As per the Press Release No. 2020-2021/520 dated October 21, 2020, Press Release No. 2020-2021/763 dated December 11, 2020, Press Release No. 2020-2021/1057 dated February 05, 2021 and Press Release No. 2021-2022/695 dated August 13, 2021.
¥ As per the Press Release No. 2014-2015/1971 dated March 19, 2015.
£  As per the Press Release No. 2021-2022/181 dated May 07, 2021 and Press Release No. 2021-2022/1023 dated October 11, 2021.
~ As per the Press Release No. 2021-2022/177 dated May 07, 2021.
ψ As per the Press Release No. 2021-2022/323 dated June 04, 2021.
Ajit Prasad
Director   
Press Release: 2021-2022/1141

[ad_2]

CLICK HERE TO APPLY

3 Stocks To Buy As Recommended By ICICI Securities with Strong Upside Potential

[ad_1]

Read More/Less


BPCL – Stake sale process to drive stock performance

The brokerage has set a target price of Rs 520 on BPCL for a 12-month period, implying a potential upside of up to 24% over the current market price of Rs 419.

Q2FY22 Results:

  • In Q2FY22, BPCL announced better-than-expected performance.
  • Revenue increased 13.3% from the previous quarter to Rs 101631.7 crore.
  • GRM came in at US$6/bbl, which was higher than expected.
  • The marketing segment saw an increase in inventories of Rs 227 crore. Subsequently,
  • EBITDA came in at Rs 4477.7 crore, up 37.7% from the previous quarter.
  • PAT came in at Rs 2694.1 crore, increasing 79.4 percent from the previous quarter.

Target and Valuation

“BPCL’s GRM improved during Q2FY22 and is likely to sustain at higher level given recovery in product cracks. We upgrade our rating on the stock from HOLD to BUY Target Price and Valuation: We value BPCL at Rs 520 i.e. average of P/BV multiple: Rs 527/share and P/E multiple: Rs 512/share,” the brokerage has said.

Key triggers for future price-performance:

Progress on divestment and favourable reaction from acquisition bidders Continued improvement in global refining product cracks (mostly diesel) Increased fuel demand and stable marketing margins.

Neogen Chemicals- Custom synthesis offers strong visibility ahead

Neogen Chemicals- Custom synthesis offers strong visibility ahead

The brokerage has set a target price of Rs 1570 on Neogen Chemicals for a 12-month period, implying a potential upside of up to 27% over the current market price of Rs 1236.

Q2FY22 Results:

  • Because of improved utilisation of recently commissioned phase 1 capacity, numbers were higher than expected.
  • Organic chemical segment (increased 36 percent YoY) and inorganic chemical segment (up 38 percent YoY) both reported revenue growth of 38 percent YoY to | 113.2 crore (up 63 percent YoY)
  • Due to the absorption of fixed overheads, gross margins fell 184 basis points year over year to 43.3 percent, while EBITDA margin fell 80 basis points to 18.1 percent.

Target and Valuation

“The stock appreciated at 65% CAGR in last two years. We retain BUY rating on the back of better growth outlook from custom synthesis business Target Price and Valuation: We value Neogen Chemicals at 40x P/E FY24E EPS to arrive at a revised target price of | 1570/share (earlier | 1515/share),” the brokerage has said.

Key triggers for future price-performance:

A higher share of value-added business portfolio to improve profits profile of firm Allocation of incremental FCF towards organic/inorganic growth expected to expand return ratios further.

Indian Oil Corporation- GRM improvement drives profitability

Indian Oil Corporation- GRM improvement drives profitability

The brokerage has set a target price of Rs 155 on Indian Oil Corporation for a 12-month period, implying a potential upside of up to 18% over the current market price of Rs 131.

Q2FY22 Results:

  • On the profitability front, IOC’s results were better than expected.
  • Revenue climbed 9.5 percent on a quarter-over-quarter basis to Rs 169770.8 crore (our estimate: | 157292 crore). Marketing revenues climbed 1% from the previous quarter to 18.9 MMT.
  • GRM was reported at US$6.6/bbl, but core GRM was US$4.8/bbl. Core GRM improved from quarter to quarter. EBITDA was Rs 10628.1 crore, down 4.5 percent from the previous quarter.

Target and Valuation

“IOC’s core GRM improved in Q2FY22. We expect it to remain at current levels in coming quarters. Steady marketing margins and further sales pick-up are expected to lead to better profitability. We maintain our BUY rating on the stock. Target Price and Valuation: We value IOC at Rs 155 i.e. average of P/E multiple: Rs 151 /share and P/BV multiple: Rs 159/share,” the brokerage has said.

Key triggers for future price-performance:

Cracks in global refining product recovery (mainly diesel)

Demand for transportation fuels will continue to rise, while marketing margins will remain stable.

To promote total profitability, petrochemical prices are at a higher level. Profitability in the pipeline segment has remained stable over the last five years.

Payout of dividends on a regular basis.

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

5 Midcap Stocks To Buy And Hold For The Festive Season

[ad_1]

Read More/Less


Tata Power

Motilal Oswal expects Solar EPC to give a leg up in earnings for the next two years. Recent award wins, particularly from NTPC, have seen its EPC order book inflate to Rs 85b, thereby providing strong visibility.

“EBITDA from Solar EPC is expected to post a 30% CAGR over FY21-23. This -coupled with the commissioning of renewable projects and the takeover of Odisha DISCOMs -should lead to a 33% PAT CAGR over FY21-23. Furthermore, the possible benefit from the merger of CGPL with itself provides an upside to profitability,” the brokerage has said.

Buy Varun Beverages

According to Motilal Oswal Varun Beverages is expected to deliver strong volume growth across all the three product segments, with an increase in consumption patterns to pre-COVID levels.

“We expect strong demand traction over the next few years due to: a) strong distribution network, b) rising penetration in the newly acquired region (south and west India), c) diversifying product portfolio, and d) growing refrigerator penetration in rural/and semi-rural areas per household and higher power availability hours. We expect a revenue/EBITDA/PAT CAGR of 20%/25%/56% over CY20-23E,” the brokerage has said.

APL Apollo

APL Apollo

Motilal Oswal also has a buy on the stock of APL Apollo. “We expect strong volume growth and improved profitability on the back of: a) increasing shift towards structural tubes (from RCC structures), b) a pan-India presence, coupled with diverse product offerings, c) behemoth market share, increasing the share of value-added products. Several cost-control measures, kicking-in of operating leverage, and growing share of VAP is expected to lead to improved margin and higher cash generation. We expect a revenue/EBITDA/PAT CAGR of 26%/26%/36% over FY21-24E,” the brokerage has said.

Orient Electric

“With demand scaling back gradually and the upcoming festive season ahead, we believe Orient Electric is best placed to capture this trend, with its strong manufacturing and distribution capabilities. We forecast a revenue/EBITDA/adjusted PAT CAGR of 19%/21%/25% over FY21-24E,” Motilal Oswal Financial Services has said.

Trident

Trident

Trident is witnessing robust demand after the lifting of COVID-related lockdown restrictions. The demand trend in Home Textiles is expected to continue, with freight cost gradually subsiding and pent-up demand in the US and Europe market. The Paper segment is expected to see a sharp recovery with the opening of offices and educational institutes.

Improvement in balance sheet of corporate India

“The country witnessed the third consecutive year of normal monsoon which is also likely to aid rural demand, and with the government balance sheet in good stead, we expect the government to press the fiscal pedal to drive growth over the next 6-12 months. Corporate India too surmounted the challenges posed by Covid with unprecedented cost containment measures with parallel improvement in balance sheet as well as cash-flows,” the brokerage has said.

Disclaimer

Disclaimer

The above stock is picked from the brokerage report of Motilal Oswal. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

2 Stocks To Buy For Gains Up To 44%: ICICI Direct

[ad_1]

Read More/Less


Buy Jindal Stainless Hisar with a target price of Rs 488

Jindal Stainless (Hisar) Limited (JSHL) is a major operator in the Indian stainless steel industry. “JSHL reported a healthy performance in Q2FY22. During Q2FY22, JSHL reported a consolidated topline of Rs 3743 crore, up 63% YoY and 35% QoQ, higher than our estimate of Rs 3465 crore. Whereas the consolidated EBITDA was at Rs 567 crore, up 95% YoY and 37% QoQ, higher than our estimate of Rs 475 crore. Consolidated PAT was at Rs 499 crore, up 196% YoY and 39% QoQ, higher than our estimate of Rs 374 crore” said the brokerage.

Key triggers for future price performance according to the brokerage

  • With respect to the precision strip division, JSHL has recently commissioned the first phase of expansion wherein the precision strip capacity has been expanded from 22000 tonnes per annum (TPA) to 48000 TPA. Going forward after the second phase, precision strip capacity would be further expanded to 60000 TPA (from 48000 TPA) which would be completed by Q4FY23. The total CAPEX for both phases is Rs 250 crore.
  • JSHL is also expanding blade steel capacity from current capacity of 14000 TPA to 24000 TPA in two phases at a total CAPEX of Rs 200 crore for both phases. After the first phase, the capacity would be expanded to 20000 TPA and is likely to be completed by Q2FY23 while post the second phase capacity would be expanded to 24000 TPA and be completed by Q2FY24.
  • For FY22, for merged entity, JSHL has upward revised its EBITDA/tonne guidance to ~Rs 24000-25000/tonne (from Rs 18000-20000/tonne earlier).

What should investors do?

JSHL’s share price has grown by ~3.5x over the last 12 months (from ~Rs 97 in October 2020 to ~Rs 339 levels in October 2021). We maintain our BUY rating on the stock. We value JSHL at Rs 488, based on the merger ratio, said the brokerage.

Buy Sumitomo Chemicals with a target price of Rs 505

Buy Sumitomo Chemicals with a target price of Rs 505

Sumitomo Chemical India (SCI) operates across the agro solutions (ASD), environmental health (EHD), and animal nutrition business verticals (AND). According to the brokerage the company has “reported revenue growth of 1% YoY to Rs 910.4 crore, impacted by sluggish growth from herbicides (-20.6% YoY). The gross margins fell 90 bps YoY to ~39% while EBITDA margin contracted 70 bps YoY to 23.6%. EBITDA was down 2% YoY to Rs 214.7 crore and PAT declined 2% YoY to Rs 154.2 crore owing to lower-than-expected operational performance.” The brokerage has also said that “overall numbers were below our estimates, impacted by subdued herbicides sales.”

Key triggers for future price performance according to the brokerage:

  • Upcoming CAPEX for five molecules, which will be supplied to SCC Japan. Capex is earmarked at Rs 100-110 crore with an asset turn of around 2-2.5x.
  • Potential opportunity of technicals manufacturing for Nufarm to improve export share meaningfully.
  • Allocation of incremental FCF towards organic/inorganic growth likely to expand return ratios further.

What should investors do?

“The stock appreciated at 63% CAGR in the last two years. We retain BUY rating on the back of a better growth outlook from the outsourcing opportunity of SCC Japan. We value Sumitomo Chemicals at 50x P/E FY23E EPS to arrive at a target price of Rs 505/share (earlier Rs 505/share)”, said the brokerage.

Disclaimer

Disclaimer

The above stocks are picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

PNB Housing Finance to raise ₹2,000 cr via NCDs in tranches

[ad_1]

Read More/Less


The Board of Directors of PNB Housing Finance Ltd (PNBHFL), on Tuesday, gave its nod for raising up to ₹2,000 crore via non-convertible debentures (NCDs) through one or more tranches.

The NCDs will be raised through private placement basis and could be both secured as well as unsecured NCDs. The details of the issue, including pricing, will be decided in the coming days.

This decision to go in for fund-raise via NCD route comes on the heels of PNBHFL board deciding not to proceed with the ₹4,000-crore preferential allotment deal with Carlyle Group and other marquee investors.

Meanwhile, PNBHFL has reported a 25 per cent decline in net profit for the second quarter ended September 30 at ₹235 crore (₹313 crore). PNBHFL had recorded a net profit of ₹243.28 crore in the first quarter this fiscal.

Total income for the quarter under review declined 21 per cent to ₹1,586 crore (₹2,022 crore). In the first quarter this fiscal, total income came in at ₹1,693 crore.

For the six months ended September 30, PNBHFL recorded net profit of ₹606 crore, compared to net profit of ₹725 crore in the same period last fiscal.

It may be recalled that the PNBHFL-Carlyle Group deal was shelved by PNBHFL after the deal had hit a roadblock post a proxy advisory firm red flagging the preferential allotment on the pricing front, contending that it was not in the interest of the promoter (PNB) as well as the minority shareholders of PNBHFL.

Market regulator SEBI had soon after this intervened and asked PNBHFL not to go ahead with the planned preferential issue until the valuation of the shares is done by an independent registered valuer.

PNBHFL had then fixed the preferential allotment price at ₹390 per share, lower than the stock price prevailing at that time. The company had preferred an appeal before the securities appellate tribunal (SAT) on the SEBI letter.

A two-member bench of the SAT, on August 9, gave a split verdict and directed that its interim order of June 21 will continue till further orders. SAT also restrained PNB Housing Finance from disclosing the voting results (of shareholders) on the fund raise plan.

Post the SAT’s split verdict, SEBI had filed an appeal at the Supreme Court against this verdict.

The Supreme Court dismissed the SEBI appeal against the SAT’s order in the PNBHFL’s ₹4,000-crore capital raising deal with Carlyle Group and other investors, stating that the appeal has become infructuous due to subsequent developments.

[ad_2]

CLICK HERE TO APPLY

1 127 128 129 130 131 16,278